Abstract
Tbx3 is a member of the T-box family of transcription factors. Mutations in Tbx3 cause ulnar-mammary syndrome, an autosomal dominant disorder characterized by upper limb defects, apocrine-gland defects including mammary hypoplasia, and tooth, hair and genital defects. In cell culture, Tbx3 and its close relative Tbx2 are capable of immortalizing mouse embryo fibroblasts. We show that expression of Tbx3 together with Myc or oncogenic Ras (H-RasVal17) leads to efficient transformation of mouse embryo fibroblasts. Oncogene cooperation by Tbx3 correlates with an ability of Tbx3 to suppress the induction of p19ARF and p53 that is typically caused by overexpression Myc and Ras, and to protect against Myc-induced apoptosis. Whereas Tbx3 is capable of interfering with apoptosis caused by excessive Myc levels, a Tbx3 mutant lacking its C-terminal repression domain shows no anti-apoptotic activity and fails to repress levels of p19ARF or p53. Consistent with an ability to suppress p53 pathway function, we find that Tbx3, but not a Tbx3 C-terminal mutant, efficiently blocks myogenic differentiation of C2C12 myoblasts. Our results support the idea that deregulation and/or excessive levels of Tbx3 may have oncogenic potential in vivo.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Agulnik SI, Garvey N, Hancock S, Ruvinsky I, Chapman DL, Agulnik I, Bollag R, Papaioannou V, Silver LM . 1996 Genetics 144: 249–254
Bamshad M, Lin RC, Law D, Watkins WC, Krakowiak PA, Moore ME, Franceschini P, Lala R, Holmes LB, Gebuhr TC, Bruneau BG, Schinzel A, Seidman JG, Seidman CE, Jorde LB . 1997 Nat. Genet. 16: 311–315
Bamshad M, Le T, Watkins WS, Dixon ME, Kramer BE, Roeder AD, Carey JC, Root S, Schinzel A, Van Maldergem L, Gardner RJ, Lin RC, Seidman CE, Seidman JG, Wallerstein R, Moran E, Sutphen R, Campbell CE, Jorde LB . 1999 Am. J. Hum. Genet. 64: 1550–1562
Basson CT, Bachinsky DR, Lin RC, Levi T, Elkins JA, Soults J, Grayzel D, Kroumpouzou E, Traill TA, Leblanc-Straceski J, Renault B, Kucherlapati R, Seidman JG, Seidman CE . 1997 Nat. Genet. 15: 30–35
Braybrook C, Doudney K, Marcano AC, Arnason A, Bjornsson A, Patton MA, Goodfellow PJ, Moore GE, Stanier P . 2001 Nat. Genet. 29: 179–183
Brummelkamp TR, Kortlever RM, Lingbeek M, Trettel F, MacDonald ME, van Lohuizen M, Bernards R . 2002 J. Biol. Chem. 277: 6567–6572
Carlson H, Ota S, Campbell CE, Hurlin PJ . 2001 Hum. Mol. Genet. 10: 2403–2413
Cerone MA, Marchetti A, Bossi G, Blandino G, Sacchi A, Soddu S . 2000 Cell Death Differ. 7: 506–508
Celli J, Duijf P, Hamel BC, Bamshad M, Kramer B, Smits AP, Newbury-Ecob R, Hennekam RC, Van Buggenhout G, van Haeringen A, Woods CG, van Essen AJ, de Waal R, Vriend G, Haber DA, Yang A, McKeon F, Brunner HG, van Bokhoven H . 1999 Cell 99: 143–153
Chapman DL, Garvey N, Hancock S, Alexiou M, Agulnik SI, Gibson-Brown JJ, Cebra-Thomas J, Bollag RJ, Silver LM, Papaioannou VE . 1996 Dev. Dyn. 206: 379–390
Chen CA, Okayama H . 1988 Biotechniques 6: 632–638
Eischen CM, Weber JD, Roussel MF, Sherr CJ, Cleveland JL . 1999 Genes Dev. 13: 2658–2669
Evan GI, Vousden KH . 2001 Nature 411: 342–348
Gibson-Brown JJ, I Agulnik S, Silver LM, Papaioannou VE . 1998 Mech. Dev. 74: 165–169
He Ml, Wen L, Campbell CE, Wu JY, Rao Y . 1999 Proc. Natl. Acad. Sci. USA 96: 10212–10217
Herrmann BG, Labeit S, Poustka A, King TR, Lehrach H . 1990 Nature 343: 617–622
Hurlin PJ, Fry DG, Maher VM, McCormick JJ . 1987 Cancer Res. 47: 5752–5757
Ianakiev P, Kilpatrick MW, Toudjarska I, Basel D, Beighton P, Tsipouras P . 2000 Am. J. Hum. Genet. 67: 59–66
Jacobs JJ, Scheijen B, Voncken JW, Kieboom K, Berns A, van Lohuizen M . 1999 Genes Dev. 13: 2678–2690
Jacobs JJ, Keblusek P, Robanus-Maandag E, Kristel P, Lingbeek M, Nederlof PM, van Welsem T, van de Vijver MJ, Koh EY, Daley GQ, van Lohuizen M . 2000 Nat. Genet. 26: 291–299
Kamijo T, Zindy F, Roussel MF, Quelle DE, Downing JR, Ashmun RA, Grosveld G, Sherr CJ . 1997 Cell 91: 649–659
Land H, Parada LF, Weinberg RA . 1983 Nature 304: 596–602
Li QY, Newbury-Ecob RA, Terrett JA, Wilson DI, Curtis AR, Yi CH, Gebuhr T, Bullen PJ, Robson SC, Strachan T, Bonnet D, Lyonnet S, Young ID, Raeburn JA, Buckler AJ, Law DJ, Brook JD . 1997 Nat. Genet. 15: 1–9
Maestro R, Dei Tos AP, Hamamori Y, Krasnokutsky S, Sartorelli V, Kedes L, Doglioni C, Beach DH, Hannon GJ . 1999 Genes Dev. 13: 2207–2217
Mateyak MK, Obaya AJ, Sedivy JM . 1999 Mol. Cell. Biol. 19: 4672–4683
McGrath JA, Duijf PH, Doetsch V, Irvine AD, de Waal R, Vanmolkot KR, Wessagowit V, Kelly A, Atherton D, Griffiths WA, Orlow SJ, van Haeringen A, Ausems MG, Yang A, McKeon F, Bamshad MA, Brunner HG, Hamel BC, van Bokhoven H . 2001 Hum. Mol. Genet. 10: 221–229
Palmero I, Pantoja C, Serrano M . 1998 Nature 395: 125–126
Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW . 1997 Cell 88: 593–602
Schinke M, Izumo S . 2001 Nat. Genet. 27: 238–240
Schinzel A . 1987 J. Med. Genet. 24: 778–781
Sharpless NE, DePinho RA . 1999 Curr. Opin. Genet. Dev. 9: 22–30
Sherr CJ, Weber JD . 2000 Curr. Opin. Genet. Dev. 10: 949–953
Smith J . 1999 Trends Genet. 15: 154–158
Spector D, Goldman RD, Leinwand LA . 1998 Cells, a laboratory manual Vol. 1: New York: Cold Spring Harbor Press
Tao W, Levine AJ . 1999 Proc. Natl. Acad. Sci. USA 96: 6937–6941
van Bokhoven H, Hamel BC, Bamshad M, Sangiorgi E, Gurrieri F, Duijf PH, Vanmolkot KR, van Beusekom E, van Beersum SE, Celli J, Merkx GF, Tenconi R, Fryns JP, Verloes A, Newbury-Ecob RA, Raas-Rotschild A, Majewski F, Beemer FA, Janecke A, Chitayat D, Crisponi G, Kayserili H, Yates JR, Neri G, Brunner HG . 2001 Am. J. Hum. Genet. 69: 481–492
Walsh K, Perlman H . 1997 Curr. Opin. Genet. Dev. 7: 597–602
Welch PJ, Wang JY . 1993 Cell 75: 779–790
Welch PJ, Wang JY . 1995 Mol. Cell. Biol. 15: 5542–5551
Zindy F, Eischen CM, Randle DH, Kamijo T, Cleveland JL, Sherr CJ, Roussel MF . 1998 Genes Dev. 12: 2424–2433
Acknowledgements
We would like to thank Scott Lowe, Arnold Levine, John Sedivy, Carla Grandori and Robert Eisenman for reagents. This work was supported by a grant from Shriners Hospitals for Children to PJ Hurlin.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Carlson, H., Ota, S., Song, Y. et al. Tbx3 impinges on the p53 pathway to suppress apoptosis, facilitate cell transformation and block myogenic differentiation. Oncogene 21, 3827–3835 (2002). https://doi.org/10.1038/sj.onc.1205476
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205476
Keywords
This article is cited by
-
Cobalt-induced oxidative stress contributes to alveolar/bronchiolar carcinogenesis in B6C3F1/N mice
Archives of Toxicology (2021)
-
The oncoprotein TBX3 is controlling severity in experimental arthritis
Arthritis Research & Therapy (2019)
-
Novel HDAC5-interacting motifs of Tbx3 are essential for the suppression of E-cadherin expression and for the promotion of metastasis in hepatocellular carcinoma
Signal Transduction and Targeted Therapy (2018)
-
The T-box transcription factor TBX3 drives proliferation by direct repression of the p21WAF1 cyclin-dependent kinase inhibitor
Cell Division (2016)
-
The transcriptional regulator TBX3 promotes progression from non-invasive to invasive breast cancer
BMC Cancer (2016)